Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Article Abstract
Major depressive disorder (MDD) is a common and debilitating condition that affects twice as many women as men. Accumulated evidence suggests that hormone fluctuations may play an important role in such increased risk for depression among females. For example, women during the menopausal transition appear to have a heightened risk for developing MDD compared with premenopausal or postmenopausal women. Overlapping depressive and menopause-related symptoms (e.g., vasomotor complaints, sleep disturbances) can complicate diagnosis and treatment, but it is vital that clinicians work to adequately tailor their treatment strategies to manage both the mood and somatic symptoms. Possible treatment options to be considered include the adequate use of hormone replacement therapy, antidepressants, psychotherapy, and other psychotropic agents.Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.